TY - JOUR
T1 - Endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging of lung cancer
AU - Nakajima, Takahiro
AU - Yasufuku, Kazuhiro
AU - Kurimoto, Noriaki
AU - Saka, Hideo
AU - Tsuboi, Masahiro
AU - Horinouchi, Hirohisa
AU - Isobe, Hiroshi
AU - Imamura, Fumio
AU - Ohno, Yasushi
AU - Sato, Masami
AU - Tsuchida, Takaaki
AU - Toga, Hirohisa
AU - Hayashi, Shinichiro
AU - Matsui, Kaoru
AU - Miyazawa, Teruomi
AU - Yokoyama, Akira
AU - Honda, Hidetoshi
AU - Shibuya, Kiyoshi
AU - Fujisawa, Takehiko
PY - 2007/6
Y1 - 2007/6
N2 - Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a new modality for the evaluation of hilar and mediastinal lymph nodes. Although many centers have adopted this new device, little has been described concerning the actual procedure and the systematic mediastinal and hilar lymph node assessment in patients with lung cancer. Here we describe the standard for systematic visualization and biopsy of mediastinal and hilar lymph nodes in patients with primary lung cancer. Lymph node stations were defined based on the General Rules for Clinical and Pathological Recording of Lung Cancer (Sixth edition), by the Japan Lung Cancer Society. Lymph nodes were scanned starting from the hilum, working up to the upper mediastinum. All enlarged lymph nodes or suspicious nodes were biopsied under real time ultrasound guidance. N3 nodes were punctured first followed by N2 and N1 nodes to avoid contamination. The diagnostic accuracy of mediastinal lymph node staging in 105 lung cancer patients was 96.3%. We have never experienced any major complication. In conclusion, EBUS-TBNA is a safe and accurate tool for the assessment of the mediastinum as well as the hilum in patients with lung cancer.
AB - Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a new modality for the evaluation of hilar and mediastinal lymph nodes. Although many centers have adopted this new device, little has been described concerning the actual procedure and the systematic mediastinal and hilar lymph node assessment in patients with lung cancer. Here we describe the standard for systematic visualization and biopsy of mediastinal and hilar lymph nodes in patients with primary lung cancer. Lymph node stations were defined based on the General Rules for Clinical and Pathological Recording of Lung Cancer (Sixth edition), by the Japan Lung Cancer Society. Lymph nodes were scanned starting from the hilum, working up to the upper mediastinum. All enlarged lymph nodes or suspicious nodes were biopsied under real time ultrasound guidance. N3 nodes were punctured first followed by N2 and N1 nodes to avoid contamination. The diagnostic accuracy of mediastinal lymph node staging in 105 lung cancer patients was 96.3%. We have never experienced any major complication. In conclusion, EBUS-TBNA is a safe and accurate tool for the assessment of the mediastinum as well as the hilum in patients with lung cancer.
KW - Convex probe ebus
KW - Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)
UR - http://www.scopus.com/inward/record.url?scp=34547617480&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547617480&partnerID=8YFLogxK
U2 - 10.2482/haigan.47.207
DO - 10.2482/haigan.47.207
M3 - Article
AN - SCOPUS:34547617480
SN - 0386-9628
VL - 47
SP - 207
EP - 214
JO - Japanese Journal of Lung Cancer
JF - Japanese Journal of Lung Cancer
IS - 3
ER -
